R & D Manager
Arnold Catsburg has since 2001 worked at the Department of Medical Microbiology and Infection Prevention, VU Medical Center, Amsterdam. His internship was focused on Real-Time PCR (TaqMan) for the qualification and quantification of Bifidobacterium, Propionibacterium and Streptococcus in mucosal biopsies from patients with inflammatory bowel disease.
After his internship, he continued to work in the field of molecular microbiology. He developed real time PCR tests including M. tuberculosis, T whipplei, Mycoplasma and Chlamydia for routine, diagnostic use. In addition, a SNP assay that was developed can be used for genotyping of MBL (Mannose Binding Lectin).
Recently he, alongside his current role, began his thesis with the focus on Chlamydia trachomatis infection.
Scientific advisory board
Prof. dr. Paul H. M. Savelkoul PhD
Paul HM Savelkoul is Professor of Medical Microbiology at Maastricht university medical centre and Amsterdam University medical center.
Prof. dr. Savelkoul is actively involved in several professional organizations, including past chairman and current board member of the European Study Group on Molecular Diagnostics. His research expertise focuses on molecular diagnostics, detection and typing of pathogenic micro-organisms.
Prof. Servaas A. Morre PhD
Prof. Servaas Morré is Head of the Laboratory of Immunogenetics, Dept. Pathology, from the VU University Medical Center, Amsterdam, NL. His research focuses on the Immunogenetics of infectious diseases including Chlamydia trachomatis, periodontitis and bacterial meningitis and on the Immunogenetics of chronic inflammatory diseases including IBD.
He has a 15 year research track record in the field of Chlamydia trachomatis. He is Scientific Director of the European FP6 EpiGenChlamydia Consortium and Chair of the European Society for Chlamydia Research for the 7th ESCR Meeting (2012) in Amsterdam. Since September 2009 he is Coordinator of the Chlamydia Diagnostic Core tasks for the Dutch National Institute of Public Health and the Environment.
As co-founder and Scientific Director he uses his network and knowledge obtained during the Masterclass BioBusiness (2009-2010) to develop new products and extend Microbiome Ltd.